Accelerating Science: How to cure the incurable with cell and gene therapy

Resolian meets the needs of preclinical and clinical programs at any scale

12 October 2023

Resolian (formerly Alliance Pharma Inc and Drug Development Solutions Ltd) is a global contract research organization (CRO) supporting pharmaceutical and biotech companies with specialized bioanalytical and analytical sciences solutions. Over 500 experts across the US, UK, and Australia, deliver quality results, ensuring the highest standard of regulatory compliance throughout the drug development continuum. 

Resolian’s specialized solutions include small and large molecule LC-MS/MS bioanalysis, PK immunoassays for large molecules, immunogenicity, biomarkers, cell-based assays, drug metabolism/pharmacokinetics (DMPK), and CMC analytical and materials science. Dedicated laboratories equipped with state-of-the-art technology meet the needs of preclinical and clinical programs at any scale.